All companies
Visit website
PherDal Fertility Science, Inc.
OperatingHealthcare · Technology · Founded 2016
Building families through science
Post-money valuation ⓘ
$14.6M
As of Dec 2022 · from PherDal Fertility Science, Inc. Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$387,017
Across 1 round since 2022
Latest share price
$1.87
PherDal Fertility Science, Inc. Common Stock 1 offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$0
$3K
2020
$0
2021
$0
−$186K
2022
$0
−$253K
2023
$92K
−$275K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$0
$0
$91,850
Cost of goods sold
$0
$0
$0
$0
$22,420
Gross margin
—
—
—
—
76%
Net income
$2,511
$0
-$186,418
-$253,435
-$275,379
Taxes paid
$0
$0
$1,048
$3,067
$7,006
Balance sheet
Cash
$6,470
$0
$167,105
$316,846
$16,830
Accounts receivable
$0
$0
$134,366
$0
$0
Total assets
$6,470
$0
$419,690
$519,162
$416,891
Short-term debt
$5,368
$0
$0
$320,000
$500,000
Long-term debt
$0
$0
$0
$0
$0
Total liabilities
$5,368
$0
$0
$320,000
$500,000
Other
Headcount
—
10
1
1
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$14.6M
post-money
PherDal Fertility Science, Inc. Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $387K / $1.1MInvestors 423Post-money $14.6M
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 3 of 4 annual reports (FY2022–FY2025)
423 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001937683Share price $1.87
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.